JPS63179824A - Antimutagnetic agent - Google Patents
Antimutagnetic agentInfo
- Publication number
- JPS63179824A JPS63179824A JP1093687A JP1093687A JPS63179824A JP S63179824 A JPS63179824 A JP S63179824A JP 1093687 A JP1093687 A JP 1093687A JP 1093687 A JP1093687 A JP 1093687A JP S63179824 A JPS63179824 A JP S63179824A
- Authority
- JP
- Japan
- Prior art keywords
- kaempferol
- mutagen
- mutagenicity
- extract
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims abstract description 36
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 20
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims abstract description 19
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 235000008777 kaempferol Nutrition 0.000 claims abstract description 18
- 239000002592 antimutagenic agent Substances 0.000 claims abstract description 4
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 239000003471 mutagenic agent Substances 0.000 abstract description 17
- 231100000707 mutagenic chemical Toxicity 0.000 abstract description 17
- 230000003505 mutagenic effect Effects 0.000 abstract description 13
- 231100000299 mutagenicity Toxicity 0.000 abstract description 11
- 230000007886 mutagenicity Effects 0.000 abstract description 11
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 7
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 229930003935 flavonoid Natural products 0.000 abstract description 7
- 150000002215 flavonoids Chemical class 0.000 abstract description 7
- 235000017173 flavonoids Nutrition 0.000 abstract description 7
- 241000196324 Embryophyta Species 0.000 abstract description 6
- -1 heterocyclic amines Chemical class 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 241000675108 Citrus tangerina Species 0.000 abstract description 3
- 240000000249 Morus alba Species 0.000 abstract description 2
- 235000008708 Morus alba Nutrition 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 abstract 1
- 244000067456 Chrysanthemum coronarium Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 244000046101 Sophora japonica Species 0.000 abstract 1
- 235000010586 Sophora japonica Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- DVCCCQNKIYNAKB-UHFFFAOYSA-N MeIQx Chemical compound C12=NC(C)=CN=C2C=CC2=C1N=C(N)N2C DVCCCQNKIYNAKB-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940119485 safflower extract Drugs 0.000 description 6
- NZRLNLVUUYPAGG-UHFFFAOYSA-N 1,4‐dimethyl‐2H‐pyrido[4,3‐b]indol‐3‐amine Chemical compound C1=CC=C2C3=C(C)NC(N)=C(C)C3=NC2=C1 NZRLNLVUUYPAGG-UHFFFAOYSA-N 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- AYLURHVFAYRSHT-UHFFFAOYSA-N Glu-P-1 Chemical compound C1=C(N)N=C2N3C=CC=C(C)C3=NC2=C1 AYLURHVFAYRSHT-UHFFFAOYSA-N 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000000711 cancerogenic effect Effects 0.000 description 3
- 231100000315 carcinogenic Toxicity 0.000 description 3
- 239000002024 ethyl acetate extract Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000219 mutagenic Toxicity 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ARZWATDYIYAUTA-UHFFFAOYSA-N 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine Chemical compound C1=CC2=NC=CC=C2C2=C1N(C)C(N)=N2 ARZWATDYIYAUTA-UHFFFAOYSA-N 0.000 description 2
- OAPVIBHQRYFYSE-UHFFFAOYSA-N 5-Phenyl-2-pyridinamine Chemical compound C1=NC(N)=CC=C1C1=CC=CC=C1 OAPVIBHQRYFYSE-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 206010007269 Carcinogenicity Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 241001125048 Sardina Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 231100000260 carcinogenicity Toxicity 0.000 description 2
- 230000007670 carcinogenicity Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 235000015205 orange juice Nutrition 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- FJTNLJLPLJDTRM-UHFFFAOYSA-N 2-Amino-9H-pyrido[2,3-b]indole Chemical compound C1=CC=C2C3=CC=C(N)N=C3NC2=C1 FJTNLJLPLJDTRM-UHFFFAOYSA-N 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- BUXVIXBGMQXWGT-UHFFFAOYSA-N Glu-P-2 Chemical compound C1=CC=CN2C3=NC(N)=CC=C3N=C21 BUXVIXBGMQXWGT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000237986 Melia azadirachta Species 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 244000018694 Sagittaria sinensis Species 0.000 description 1
- 235000015909 Sagittaria sinensis Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- OUGIDAPQYNCXRA-UHFFFAOYSA-N beta-naphthoflavone Chemical compound O1C2=CC=C3C=CC=CC3=C2C(=O)C=C1C1=CC=CC=C1 OUGIDAPQYNCXRA-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003239 environmental mutagen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JSXZMKNQTHRIJD-UHFFFAOYSA-N lys-p-1 Chemical compound N1C2=CC=CC=C2C2=C1C1=CC=CN=C1C1=C2CCC1 JSXZMKNQTHRIJD-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 230000002352 nonmutagenic effect Effects 0.000 description 1
- NZLRKRKOVVXDLV-UHFFFAOYSA-N orn-p-1 Chemical compound C1=NCN2C3=NC=CC=C3C3=C2C1=C(N)N=C3C NZLRKRKOVVXDLV-UHFFFAOYSA-N 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、フラボノイドの一種であるケンフェロールを
含有することを特徴とする安全性が高く効果に優れた、
食品用の抗変異原性剤に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention provides a highly safe and highly effective product containing kaempferol, which is a type of flavonoid.
Concerning antimutagenic agents for food.
[従来の技術]
現在、日本では、癌(悪性新生物)が死因の第1位を占
めており、また、ヒトの癌発生の大部分は、環境中の発
癌因子に起因していると考えられている。この環境中に
存在する発癌因子としては、我々が日常摂取する飲食品
が最も重要視されているし、こうした見解を支持する疫
学的データは枚挙にいとまがない。[Prior Art] Currently, cancer (malignant neoplasm) is the leading cause of death in Japan, and it is believed that most human cancers are caused by carcinogenic factors in the environment. It is being Among the carcinogenic factors that exist in this environment, the foods and drinks we consume on a daily basis are considered the most important, and there is an overwhelming amount of epidemiological data that supports this view.
飲食品や医薬品などの環境因子の発癌性を予見する手段
として、近年、ヒスチジンの要求性を指標としたニーム
ステストが確立された( Ames、 B。In recent years, the Neems test, which uses histidine requirement as an index, has been established as a means of predicting the carcinogenicity of environmental factors such as foods and drinks and medicines (Ames, B.
N、 et al、:Mutation Res、、
Vol 31.347. ’75)。N. et al.: Mutation Res.
Vol 31.347. '75).
この方法で調べられた化合物の突然変異原性と発癌性の
間には80〜90%の高い相関性があることが多くの研
究機関で認められている( McCann。Many research institutions have found a high correlation of 80-90% between the mutagenicity and carcinogenicity of compounds tested using this method (McCann).
J、 et al、:Proc、 Natl、 Aea
d、 Sci、 (U、S、A、)。J, et al.: Proc, Natl, Aea
d, Sci, (U, S, A,).
Vol、 72.5135. ’75 )。Vol, 72.5135. ’75).
よって、突然変異原性をなくすことは発癌の危険性から
ヒトを守る上で少なからぬ効果が期待゛される。また、
そればかりか、突然変異は遺伝子であるDNAに対する
障害の結果として起こるものであり、仮に発癌まで至ら
なかったとしても変異原物質のヒトの健康に及ぼす影響
は決して軽視できるものではない。突然変異原性のない
飲食品が望まれる所以である。現在までに、飲食品中に
存在する変異原物質としては、亜硝酸と二級アミンの反
応によって生成するニトロソアミン類、食品の焼けこげ
の中に存在するヘテロサイクリックアミン類、アフラト
キシンなどのマイコトキシン類などが知られており、発
癌性が証明されているものが多い。しかし、飲食品は我
々が日常的に摂取しているものであり、我々は、これら
の変異原物質を知らず知らずのうちに少なからず摂取し
てしまっている。特に食品の焼けとげの中に存在するヘ
テロサイクリックアミン類には高い突然変異原性を示す
ものが多い(表1参照、エンバイロンメンタル ミュー
タジエンズ アンド カルシノジエンズ(Enviro
nmental Muta3ens and Carc
ino−gens )、ユニバーシティ オブ トウキ
ヨウ プレス(Univercity of Toky
o Press、 Tokyo )、7頁、1981よ
り抜粋)。Therefore, eliminating mutagenicity is expected to have a considerable effect on protecting humans from the risk of carcinogenesis. Also,
Moreover, mutations occur as a result of damage to DNA, which is genes, and even if they do not lead to cancer, the effects of mutagens on human health cannot be underestimated. This is why food and drink products that are not mutagenic are desired. To date, the mutagens present in food and beverages include nitrosamines produced by the reaction of nitrous acid and secondary amines, heterocyclic amines present in burnt food, and mycotoxins such as aflatoxin. Many of them have been proven to be carcinogenic. However, food and drinks are things we ingest on a daily basis, and we often ingest these mutagens without realizing it. In particular, many of the heterocyclic amines present in burnt food are highly mutagenic (see Table 1).
nmental Muta3ens and Carc
ino-gens), University of Tokyo Press
(Excerpt from O Press, Tokyo), p. 7, 1981).
(以下余白)
表1 食品の焼けとげの中に存在するヘテロサイクリッ
クアミン類の突然変異原性
*略称 単離したもと ):(*変異活性M
eIQ 焼いたいわし 6610
00IQ 焼いたいわし 43
3000MeIQx 焼肉
1.45000Trp−P−2)リプトファンの加熱
104000生成物(以下、同様)
Orn−P−1オルニチン 56800
Glu−P−1グルタミン酸 4.900
0Trp−P−1トリプトファン 390
00Glu−P−2グルタミン酸 19
00AαC大豆グロブリン 300MeA
αC大豆グロブリン 200Lys−P−
1リジン 86Phe−P−1
フェニルアラニン 41>:ζMeIQ
: 2−アミノ−8,4,−ジメチルイミダゾ[4−,
5−f]キノリン、IQ:2−アミノ−3−メチルイミ
ダゾ[4,5−f]キノリン、MeIQx : 2−ア
ミノ−3,8−ジメチルイミダゾ[4,5−f]キノキ
サリン、Trp−P−2: 3−アミノ−1−メチル−
5H−ピリド[4,3−b]インドール、0rn−P−
1: 4−アミノ−6−メチル−1,H−2,5,10
,10b−テトラアザフルオランテン、Glu−P−1
,: 2−アミノ−6−メチルジピリド[1,2−a:
3°、2“−d]イミダゾール、Trp−P−1: 3
−アミノ−1゜4−ジメチル−5H−ピリド[4,3−
b]インドール、Glu−P−2: 2−アミノジピリ
ド[1゜2−a:3’、2’−d]イミダゾール、Aa
C:2−アミノ−9H−ピリド[2,3−b]インドー
ル、MeAαC:2−アミノ−8−メチル−9H−ピリ
ド[2,3−b]インドール、Lys−P−1:3,4
−シクロペンチノビリド[3,2−a]カルバゾール、
Phe−P−1: 2−アミノ−5−フェニルピリジン
*〉:ζサルモネラ・ティフィムリウム(Sa1mon
e月−a typhimurium ) TA98株を
用い、ラット肝ホモジネート(S9ミツクス)の存在下
で実験を行った結果。検体1μgあたりで生じた復帰変
異コロニー数。(Left below) Table 1 Mutagenicity of heterocyclic amines present in burnt food *Abbreviation Isolated source ): (*Mutation activity M
eIQ Grilled Sardine 6610
00IQ Grilled Sardine 43
3000MeIQx Yakiniku
1.45000 Trp-P-2) Heating of liptophan 104000 Product (hereinafter the same) Orn-P-1 Ornithine 56800
Glu-P-1 glutamic acid 4.900
0Trp-P-1 tryptophan 390
00Glu-P-2 glutamic acid 19
00AαC soybean globulin 300MeA
αC soybean globulin 200Lys-P-
1 Lysine 86Phe-P-1
Phenylalanine 41>:ζMeIQ
: 2-amino-8,4,-dimethylimidazo[4-,
5-f]quinoline, IQ: 2-amino-3-methylimidazo[4,5-f]quinoline, MeIQx: 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, Trp-P- 2: 3-amino-1-methyl-
5H-pyrido[4,3-b]indole, 0rn-P-
1: 4-amino-6-methyl-1,H-2,5,10
, 10b-tetraazafluoranthene, Glu-P-1
,: 2-amino-6-methyldipyrido [1,2-a:
3°,2“-d]imidazole, Trp-P-1: 3
-Amino-1゜4-dimethyl-5H-pyrido[4,3-
b] Indole, Glu-P-2: 2-aminodipyrido[1°2-a:3',2'-d]imidazole, Aa
C: 2-amino-9H-pyrido[2,3-b]indole, MeAαC: 2-amino-8-methyl-9H-pyrido[2,3-b]indole, Lys-P-1: 3,4
- cyclopentinoviride [3,2-a]carbazole,
Phe-P-1: 2-amino-5-phenylpyridine *>: ζ Salmonella typhimurium (Sa1mon
Results of an experiment using the TA98 strain (A typhimurium) in the presence of rat liver homogenate (S9 mix). Number of revertant colonies generated per 1 μg of sample.
(以下余白)
本発明は、飲食品の突然変異原性を消失させるか又はこ
れを減弱させることによって、飲食品の安全性を向上さ
せようとするものである。この分野の研究については今
日までに多くの成果が出ており、フラボノイドについて
も煙草の煙や自動車の排気ガス中に存在するベンゾ[a
]ピレンなどの多環芳香族炭化水素系の変異原物質に対
して抑制作用を示すことは知られていた(カルシノジェ
ネシス(Carcinogenesis )第4巻、第
1631〜1637頁、1983 )。(The following is a blank space) The present invention aims to improve the safety of food and drink products by eliminating or attenuating their mutagenicity. Research in this field has produced many results to date, and flavonoids are also present in benzo [a], which is present in cigarette smoke and automobile exhaust gas.
] It was known that it exhibits an inhibitory effect on polycyclic aromatic hydrocarbon mutagens such as pyrene (Carcinogenesis, Vol. 4, pp. 1631-1637, 1983).
[発明が解決しようとする問題点]
本発明者らは、前記の目的を達成するために、鋭意研究
に努めた結果、ここにケンフェロールが食品中の変異原
物質、特に焼けこげの中に存在するヘテロサイクリック
アミン類に対して強い抑制効果を示す事実を発見した。[Problems to be Solved by the Invention] In order to achieve the above object, the present inventors have made extensive research efforts and have found that kaempferol is a mutagen in foods, particularly in burnt food. We have discovered that this product has a strong inhibitory effect on existing heterocyclic amines.
上記成分による突然変異原性のない飲食品の製造、ある
いは、飲食品の突然変異原性をなくすための、上記成分
の用途はまったく新規である。The use of the above ingredients to produce non-mutagenic foods and drinks, or to eliminate the mutagenicity of foods and drinks, is completely new.
[問題点を解決するための手段]
すなわち、本発明は、有効成分としてケンフェロールを
含有することを特徴とする、食品用の抗変異原性剤であ
る。[Means for Solving the Problems] That is, the present invention is an antimutagenic agent for food, which is characterized by containing kaempferol as an active ingredient.
以下本発明の構成について詳述する。The configuration of the present invention will be explained in detail below.
本発明で用いられるケンフェロールは、天然界では高等
植物に存在する。本発明においてはケンフェロールを合
成あるいは植物等から抽出単離して用いてもよいし、植
物抽出物として用いてもよい。そのような植物としては
、例えばベニバナ、エンジュ、ダイダイ、ミカン、セン
ブリ、クワ、カンゾウ、コガネバナ、カワラヨモギ、ク
ズ等を挙げることができる。Kaempferol used in the present invention naturally exists in higher plants. In the present invention, kaempferol may be synthesized or extracted and isolated from plants, etc., or may be used as a plant extract. Examples of such plants include safflower, apricot, Japanese daisy, tangerine, Japanese tangerine, mulberry, daylily, scutellaria, mugwort, kudzu, and the like.
苦杯によると、ガスコンロ上で焼いた牛肉及び鶏肉、及
び電熱式ホットプレート上で焼いた牛肉から検出された
MelQxはそれぞれ焼いた肉1g当たり0.5 ng
、 2.1 ng及び0.3 ngであった(環境変異
原研究、第7巻、第1号、第35〜41頁、1985
)。According to Kuwai, MelQx detected in beef and chicken grilled on a gas stove and beef grilled on an electric hot plate was 0.5 ng per gram of grilled meat.
, 2.1 ng and 0.3 ng (Environmental Mutagen Research, Vol. 7, No. 1, pp. 35-41, 1985
).
MeIQxのみでこれら焼いた肉類の変異原性のすべて
を説明できるわけではないが、ケンフェロールを、これ
らの変異原物質の3倍量を添加するととにより、その変
異原性を50%抑制することができる。仮に、焼いた内
申にこの10倍の変異原物質が存在したとして、1回に
食べる焼肉の量を1008とすると摂取される変異原の
量は最も多いガスコンロで焼いた鶏肉で2.1 μgと
なり、これに対して必要なケンフェロールの量は6.3
μgとなる。100%抑制が望まれる場合にはさらにこ
の10倍量、すなわち63Pgを用いれば充分である。Although MeIQx alone cannot explain all of the mutagenicity of these grilled meats, adding kaempferol at three times the amount of these mutagens suppressed the mutagenicity by 50%. Can be done. Assuming that 10 times more mutagens were present in the grilled meat, and the amount of yakiniku eaten at one time was 1008, the amount of mutagen ingested would be 2.1 μg for chicken grilled on a gas stove. , the amount of kaempferol required for this is 6.3
It becomes μg. If 100% suppression is desired, it is sufficient to use 10 times this amount, that is, 63Pg.
これは肉に対する重量比にするとわずか0.63ppm
と極めて微″量で充分な効果をもつと言える。[発明の
効果]つぎに、試験例によって、本発明の詳細な説明す
る。This is only 0.63 ppm in weight ratio to meat.
It can be said that a sufficient effect can be obtained with an extremely small amount. [Effects of the Invention] Next, the present invention will be explained in detail with reference to test examples.
(試験例)
■、変異原抑制作用の測定方法
(1)方法:プレインキュベーション法(杉材、長足:
ケミカル ミュータジエンズ(ChemiCalMut
agens )、第6巻、41頁、1981 )による
。(Test example) ■Measurement method of mutagen suppression effect (1) Method: Pre-incubation method (cedar wood, long legs:
Chemical Mutadiens (ChemiCalMut)
Gens), Vol. 6, p. 41, 1981).
(11)使用菌株:ヒスチジン要求性のサルモネラティ
フィムリウム(Salmonella ty hymu
rium )TM01株(以下、TM98と略す)。(11) Bacterial strain used: histidine auxotrophic Salmonella typhimurium (Salmonella typhimurium)
rium ) TM01 strain (hereinafter abbreviated as TM98).
(il+ )試料の調製
1)ケンフェロールおよびその他のフラボノイド(標品
)の場合:これらはジメチルスルフォキサイド(以下、
DMSOと略す)に溶かす。(il+) Sample preparation 1) For kaempferol and other flavonoids (standard): These are dimethyl sulfoxide (hereinafter referred to as
Dissolve in DMSO (abbreviated as DMSO).
2)ベニバナ抽出物の場合:ベニバナを酢酸エチルで抽
出し、その抽出液を蒸発・乾固させて、ベニバナ酢酸エ
チル抽出物を得た。また、ベニバナを熱水で抽出して得
た抽出物をさらにアセトンで抽出し、得られた抽出物を
活性炭処理によって精製し、ベニバナエキスを得た。こ
れらもDMSOに溶がした。2) In the case of safflower extract: Safflower was extracted with ethyl acetate, and the extract was evaporated to dryness to obtain an ethyl acetate extract of safflower. Furthermore, the extract obtained by extracting safflower with hot water was further extracted with acetone, and the obtained extract was purified by activated carbon treatment to obtain a safflower extract. These were also dissolved in DMSO.
(iv )変異原性の測定
前記(iil )の1)と2)により得られた各試料5
0μlに・500μmの89ミツクス(フエノパルビタ
ールと5,6−ベンゾフラボンで薬物代謝酵素系を誘導
したラットの肝臓のホモジェネートの9000Xg上清
にニコチンアミドアデニンジヌクレオチド(NADH)
、ニコチンアミドアデニンジヌクレオチドリン酸(NA
DPH)及びグルコース−6−リン酸(06P)などの
補酵素、マグネシウムイオン(Mg2+)などを加えた
もの)、100μlのTA98株前培養液及び50μm
の変異原物質(Trp−P−1,Glu−P−1,IQ
など)の水溶液を加える。この混合液を37℃で20分
間振盪後、微量のヒスチジン、ビオチンを含む溶解した
2 mlの軟寒天に混ぜ、最少グルコース寒天培地上に
まく。37℃で48時間静置後、培地上のヒスチジン非
要求性の復帰変異コロニー数を数える。なお、変異原性
の抑制作用は変異原物質のみを添加した培地上に生じた
コロニー数を100とし、ケンフェロールを加えた場合
、それがどの程度に減少したかを上記コントロールに対
する割合で示した。算出式は下記に示した。(iv) Measurement of mutagenicity Each sample 5 obtained in 1) and 2) of (iil) above
Add nicotinamide adenine dinucleotide (NADH) to 0 μl and 500 μm of 89 mix (9000×g supernatant of rat liver homogenate in which the drug-metabolizing enzyme system was induced with phenoparbital and 5,6-benzoflavone).
, nicotinamide adenine dinucleotide phosphate (NA
DPH) and coenzymes such as glucose-6-phosphate (06P), magnesium ions (Mg2+), etc.), 100 μl of TA98 strain preculture solution and 50 μm
mutagens (Trp-P-1, Glu-P-1, IQ
etc.). After shaking this mixture at 37°C for 20 minutes, it is mixed with 2 ml of dissolved soft agar containing trace amounts of histidine and biotin, and spread on a minimum glucose agar medium. After standing at 37°C for 48 hours, count the number of revertant colonies that do not require histidine on the medium. In addition, the mutagenicity suppressing effect is calculated based on the number of colonies generated on the medium containing only the mutagen as 100, and the extent to which the number of colonies decreased when kaempferol was added is expressed as a percentage of the above control. . The calculation formula is shown below.
A=l(B−C)÷(D−C) l X100A:フラ
ボノイド無添加コントロールに対する割合(%)
B:フラボノイド添加培地のコロニー数C:溶媒コント
ロール培地のコロニー数り=フラボノイド無添加コント
ロール培地のコロニー数
II 、結果
(i)ケンフェロールの変異原抑制作用結果は表にして
以下に示した。A=l(B-C)÷(D-C)l Number of Colonies II, Results (i) Mutagen Suppression Effect of Kaempferol The results are shown in the table below.
フラボノイド 50%抑制量(ng )クエルセ
チン 390 450 150ケンフエロール
130 140 100フイセチン 5
70 1350 1320モリン 1.1
50 2390 2120ミリセチン 35
0 350 320*:添加量はTrp−P−1:
42 ng、、 Glu−P−C40ng。Flavonoid 50% inhibition amount (ng) Quercetin 390 450 150 Kaempferol 130 140 100 Phisetin 5
70 1350 1320 Morin 1.1
50 2390 2120 Myricetin 35
0 350 320*: Addition amount is Trp-P-1:
42 ng, Glu-P-C 40 ng.
IQ:10 ngとした。IQ: 10 ng.
表中の値は、変異原物質の変異原性を50%抑制するの
に必要なフラボノイドの量を示したものである。ケンフ
ェロールは、他のフラボノイドに比較して抑制作用が強
く、Trp−P−1,Glu−P−1を対象とした場合
、例えばクエルセチンの約3分の1の量で効果を示すこ
とがわかった。The values in the table indicate the amount of flavonoid required to suppress the mutagenicity of the mutagen by 50%. Kaempferol has a stronger inhibitory effect than other flavonoids, and when targeting Trp-P-1 and Glu-P-1, it has been shown to be effective at about one-third the amount of quercetin, for example. Ta.
(it )ベニバナ抽出物の変異原抑制作用結果は図1
および2に示した。変異原物質としては、ここではTr
p−P−1(42ng)を用いた。50%抑制量は、ベ
ニバナ酢酸エチル抽出物で<Img、ベニバナエキスで
2.7 mgだった。(it) The results of the mutagenic inhibitory effect of safflower extract are shown in Figure 1.
and 2. Here, as a mutagen, Tr
p-P-1 (42 ng) was used. The 50% inhibition amount was <Img for Safflower ethyl acetate extract and 2.7 mg for Safflower extract.
[実施例] 以下に実施例を示して、本発明をより詳細に説明する。[Example] EXAMPLES The present invention will be explained in more detail with reference to Examples below.
本発明はこれらに限定されるものではない。The present invention is not limited to these.
実施例1ニオレンジジユース
濃縮オレンジ果汁 190g砂
糖 260 gクエ
ン酸 2g香料
4.5gケンフェロ
ール 3 mg純水で全量を3
000gにあわせる。Example 1 Orange juice concentrate 190g Sugar 260g Citric acid 2g Flavoring
4.5g Kaempferol 3mg Dilute the total amount with 3mg pure water
Adjust to 000g.
上記の処方でオレンジジュースを得た。Orange juice was obtained with the above recipe.
実施例2:混合果実飲料
パッション果汁 200gオ
レンジピユーレ−1008
リンゴ濃縮果汁 10 g砂
糖 100gクエ
ン酸 0.4gベニバ
ナエキス 0.688純水で全
量を1000m lとする。Example 2: Mixed fruit drink Passion juice 200g Orange Piure - 1008 Apple juice concentrate 10g Sugar 100g Citric acid 0.4g Safflower extract 0.688 The total volume was made up to 1000ml with pure water.
上記の処方で混合果実飲料を得た。A mixed fruit drink was obtained with the above formulation.
図1および2は、それぞれベニバナ酢酸エチル抽出物、
ベニバナエキスのTrp−P−1に対する抑制作用を示
したもので、横軸はプレートあたりに加えた抽出物の量
(mg:ミリグラム)、縦軸は生じた復帰変異コロニー
数を抽出物を加えないコントロールプレートのコロニー
数(これを100とする)に対する割合で示したもので
ある。Figures 1 and 2 show safflower ethyl acetate extract,
This shows the inhibitory effect of safflower extract on Trp-P-1. The horizontal axis is the amount of extract added per plate (mg: milligrams), and the vertical axis is the number of reverted mutation colonies that occurred without adding the extract. It is shown as a ratio to the number of colonies on the control plate (this is taken as 100).
Claims (1)
する、食品用の抗変異原性剤。An antimutagenic agent for food, characterized by containing kaempferol as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1093687A JPS63179824A (en) | 1987-01-20 | 1987-01-20 | Antimutagnetic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1093687A JPS63179824A (en) | 1987-01-20 | 1987-01-20 | Antimutagnetic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63179824A true JPS63179824A (en) | 1988-07-23 |
Family
ID=11764108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1093687A Pending JPS63179824A (en) | 1987-01-20 | 1987-01-20 | Antimutagnetic agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63179824A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004123728A (en) * | 2002-09-09 | 2004-04-22 | New Industry Research Organization | Noble flavonoid compound and its utilization |
JP2007084446A (en) * | 2005-09-20 | 2007-04-05 | Pola Chem Ind Inc | Skin lotion |
-
1987
- 1987-01-20 JP JP1093687A patent/JPS63179824A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004123728A (en) * | 2002-09-09 | 2004-04-22 | New Industry Research Organization | Noble flavonoid compound and its utilization |
JP4587652B2 (en) * | 2002-09-09 | 2010-11-24 | 株式会社フラバミン | Novel flavonoid compounds and their use |
JP2007084446A (en) * | 2005-09-20 | 2007-04-05 | Pola Chem Ind Inc | Skin lotion |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tønnesen et al. | Studies on curcumin and curcuminoids IX: investigation of the photobiological activity of curcumin using bacterial indicator systems | |
AU602011B2 (en) | Food supplements | |
Amorini et al. | Activity and mechanism of the antioxidant properties of cyanidin-3-O-β-glucopyranoside | |
Drawert et al. | Biosynthesis of flavor compounds by microorganisms. 3. Production of monoterpenes by the yeast Kluyveromyces lactis | |
Kovary et al. | Biochemical behaviour of norbixin during in vitro DNA damage induced by reactive oxygen species | |
EP0692934A4 (en) | Lipid-soluble green tea catechin antioxidant solutions | |
Whong et al. | Comparative antimutagenicity of chlorophyllin and five other agents against aflatoxin B1‐induced reversion in Salmonella typhimurium strain TA98 | |
Platel et al. | Nutritional profile of chekurmanis (Sauropus androgynus), A less explored green leafy vegetable | |
Özen et al. | Antioxidant activities of Sarcodon imbricatum wildly grown in the black sea region of Turkey | |
JPH06312924A (en) | Utilization of humulones having antioxidant action | |
US6423365B1 (en) | Method and compositions producing cherry derived products | |
WO1994022322A1 (en) | Solid microcrystalline green tea catechin antioxidants for lipids | |
JPS63179824A (en) | Antimutagnetic agent | |
Alaiz et al. | Natural antioxidants produced in oxidized lipid/amino acid browning reactions | |
KR100304430B1 (en) | Health-improving food composition comprising ginseng and citrus peel derivative | |
Farag et al. | Degradation of the natural mutagenic compound safrole in spices by cooking and irradiation | |
JP3683010B2 (en) | Method for producing antioxidant substance and use thereof | |
Hayes et al. | Effect of aflatoxin B1, ochratoxin A and rubratoxin B on infant rats | |
KR101935689B1 (en) | Composition comprising mixture extract of jujube, licorice and platycodon for enhancing immune response | |
Münzner | Modifying action of vegetable juice on the mutagenicity of beef extract and nitrosated beef extract | |
Docheva et al. | Antioxidant activity and chemical composition of crude extracts from different tobaccos and tobacco blends | |
KR20220097149A (en) | Method for producing broccoli powder with enhanced glucoraphanin content | |
Zafar et al. | A study on the analysis of ochratoxin-A in different poultry feed ingredients | |
JPH0753397A (en) | Mutagenicity-inhibiting agent | |
CN102077931A (en) | Preparation method of bionic enzyme type water-soluble nitrite composite degradation agent |